Scientist, high-throughput transient transfectio, Pfizer, Inc.
Biography
2000-2001 Genzyme Biosurgery, GMP Culture of autologous chondrocytes for knee replacement surgery
2001-2002 Harvard School of Public Health, Responsible for culturing of Human Airway Smooth Muscle cells for asthma research
2002-2007 ImmunoGen, Responsible for the stable cell line development of DG44CHO cells secreting monoclonal antibodies
2007-2010 Organon/Schering-Plough/Merck, Responsible for the stable and large scale transient development of DG44CHO and Hek293F cells to produce monoclonal antibodies
2010-Present Pfizer, Responsible for large scale and small scale transient expression of proteins in various formats using the Expi293F transient transfection platform. Currently working in the High Throughput Transient transfection group
2001-2002 Harvard School of Public Health, Responsible for culturing of Human Airway Smooth Muscle cells for asthma research
2002-2007 ImmunoGen, Responsible for the stable cell line development of DG44CHO cells secreting monoclonal antibodies
2007-2010 Organon/Schering-Plough/Merck, Responsible for the stable and large scale transient development of DG44CHO and Hek293F cells to produce monoclonal antibodies
2010-Present Pfizer, Responsible for large scale and small scale transient expression of proteins in various formats using the Expi293F transient transfection platform. Currently working in the High Throughput Transient transfection group
